Voltaren Emulgel gel for external use

Nazione: Armenia

Lingua: inglese

Fonte: Դեղերի և բժշկական տեխնոլոգիաների փորձագիտական կենտրոնի գործունեության Հայաստանի Հանրապետությունում

Principio attivo:

diclofenac (diclofenac diethylamine)

Commercializzato da:

GlaxoSmithKline Consumer Healthcare S.A.

Codice ATC:

M02AA15

INN (Nome Internazionale):

diclofenac (diclofenac diethylamine)

Dosaggio:

20mg/g

Forma farmaceutica:

gel for external use

Confezione:

50g laminated tube, 100g laminated tube

Tipo di ricetta:

OTC

Stato dell'autorizzazione:

Registered

Data dell'autorizzazione:

2020-09-05

Scheda tecnica

GSK Consumer Healthcare S.A.,
Switzerland.
Summary of Product Characteristics
Global Labeling
VOLTAREN EMULGEL
Gel
Diclofenac diethylamine 2.32%
SUMMARY OF PRODUCT CHARACTERISTICS
Document status:
FINAL
Release date:
13 Apr 2020
Number of pages:
8
GSK Consumer Healthcare S.A.,
Switzerland.
Summary of Product Characteristics
TABLE OF CONTENTS
1
NAME OF THE MEDICINAL PRODUCT
.......................................................................
3
2
QUALITATIVE AND QUANTITATIVE COMPOSITION
............................................. 3
3
PHARMACEUTICAL FORM
............................................................................................
3
4
CLINICAL PARTICULARS
..............................................................................................
3
4.1
Pharmacotherapeutic group
.....................................................................................
3
4.2
Posology and method of administration
.................................................................. 3
4.3
Contraindications
.....................................................................................................
4
4.4
Special warnings and precautions for use
................................................................ 4
4.5
Interaction with other medicinal products and other forms of
interaction .............. 5
4.6
Pregnancy and lactation
...........................................................................................
5
4.7
Effects on ability to drive and use machines
........................................................... 5
4.8
Undesirable effects
..................................................................................................
5
4.9
Overdose
..................................................................................................................
6
5 PHARMACOLOGICAL PROPERTIES
..........................................................................
6
5.1 Pharmacodynamic properties
....................................................................................